Lichen Sclerosus Treatment Market to Grow at High CAGR of 7.8% with AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Sanofi S.A. and Many till 2023

Lichen Sclerosus is underdiagnosed condition of the anogenital region. It is often painful and itchy and may cause sexual and urinary dysfunction. Increasing prevalence of skin diseases worldwide is one of the major factors contributing to the growth of the market. Moreover, hormonal misbalance in females undergoing menopause are more susceptible to lichen sclerosus, which boosts the growth of market. On the other hand, availability of exact treatment, and unawareness about rare skin diseases among people may hamper the market growth.

Prevalence of skin diseases is increasing across the globe. People are unaware of most of the rare skin diseases, which is one of the driving factors of the market. Moreover, lichen sclerosus treatment market is driven by growing prevalence of this disease in both developed and developing countries. Additionally, increasing geriatric population with skin disease, which remain untreated for a long period of time boost the market growth.

Lichen sclerosus is a skin disease that affects the genital and anal areas. In some cases, they may appear on upper body such as arms and breast regions. The main cause of lichen sclerosus is still unknown, but some of the other causes are hormonal imbalance, hyper immunity reactions. Patients with skin destruction around genital or anal region are more susceptible to develop lichen sclerosus. Generally women suffering from vulva’s lichen sclerosus are at a high risk of developing vulvar cancer. Increasing prevalence of skin diseases worldwide is one of the major factors contributing to the growth of the market. Moreover, hormonal misbalance in females undergoing menopause are more susceptible to lichen sclerosus, which boosts the growth of market.

On the other hand, availability of exact treatment, and unawareness about rare skin diseases among people may hamper the market growth. The Global Lichen Sclerosus Treatment Market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to reach USD 150 million by 2023.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4265

Lichen Sclerosus Treatment Market - Major Players

Some of the key players in the global market are:

AstraZeneca plc
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Johnson & Johnson Services Inc.
Merck & Co. Inc.
Pfizer Inc.
Sandoz AG (Novartis AG)
Sanofi S.A.
Valeant Pharmaceuticals
Zylera Pharmaceuticals

Lichen Sclerosus Treatment Market - Segmentation

The global sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy, and surgery. His drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. The surgery is further segmented into laser surgery, circumcision, and others. On the basis of mode of administration, the market is segmented into oral, topical, IV (Intravenous), and others. The oral administration is further segmented into tablets, capsule and others. The topical administration is further segmented into creams, ointment, and others. On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.

Lichen Sclerosus Treatment Market - Regional Analysis

The global lichen sclerosus treatment market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global lichen sclerosus treatment market. It comprises of two regions namely North America and South America. North America is the largest market owing to rising prevalence of skin diseases in the American counties and increasing geriatric population with skin diseases. According to the American Academy of Dermatology, 50% of Americans over age 65 have skin disease.

In the Europe, extensive demand for skin care and topical products to treat skin diseases drives the market growth. Moreover, increasing investment in research & development in developing new treatment methods for skin related diseases add fuel to the growth of the market.

Asia Pacific is the fastest growing and potential market for the lichen sclerosus treatment owing to increasing number of dermatology clinics and rising prevalence of lichen sclerosus in the developing countries. Rising prevalence of vulva’s lichen sclerosus in women act as a risk factor for vulvar cancer also drives the growth of this market.

The Middle East & Africa is expected witness steady growth due to rising demand for primary healthcare services such as diagnosis and medical devices.

Browse Complete 110 Pages Premium Research Report Enabled with 121 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/lichen-sclerosus-treatment-market-4265

Major Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

Continued…

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.